HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Race and long-acting antipsychotic prescription at a community mental health center: a retrospective chart review.

AbstractOBJECTIVE:
There has been concern that racial minorities are disproportionately prescribed long-acting injectable antipsychotic drugs.
METHOD:
Comprehensive administrative data and clinician survey were used to identify all patients with a DSM-IV diagnosis of schizophrenia who received long-acting antipsychotic prescriptions from July 2009 to June 2010 at a community mental health center. Charts were reviewed retrospectively to validate long-acting antipsychotic prescription (eg, medication, dosage) and merged with administrative data from all center patients documenting sociodemographic characteristics (ie, age, race, gender) and comorbid diagnoses. We used bivariate χ2, t tests, and multivariate logistic regression to compare the subsample of patients receiving long-acting injectable drugs (n = 102) to patients not receiving long-acting injectable drugs (n = 799) who were diagnosed with schizophrenia for the same period.
RESULTS:
White patients were significantly less likely to receive long-acting antipsychotic prescriptions than minority patients (OR = 0.52, P < .007); ie, nonwhites were 1.89 times more likely to receive such drugs. Age, gender, and comorbid diagnoses, including substance abuse, were unrelated to long-acting injectable prescription, and race/ethnicity was not associated with use of specific agents (haloperidol decanoate, fluphenazine decanoate, or risperidone microspheres) (P = .73).
CONCLUSIONS:
Racial minorities are more likely than other patients with schizophrenia to receive long-acting injectionable antipsychotics, a finding that suggests their prescribers may consider them less adherent to antipsychotic prescriptions.
AuthorsNeil Krishan Aggarwal, Robert A Rosenheck, Scott W Woods, Michael J Sernyak
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 73 Issue 4 Pg. 513-7 (Apr 2012) ISSN: 1555-2101 [Electronic] United States
PMID22579151 (Publication Type: Journal Article)
Copyright© Copyright 2012 Physicians Postgraduate Press, Inc.
Chemical References
  • Antipsychotic Agents
  • Delayed-Action Preparations
Topics
  • Antipsychotic Agents (administration & dosage, therapeutic use)
  • Black People (statistics & numerical data)
  • Chi-Square Distribution
  • Community Mental Health Centers (statistics & numerical data)
  • Delayed-Action Preparations
  • Female
  • Healthcare Disparities
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Psychotic Disorders (drug therapy)
  • Racial Groups (statistics & numerical data)
  • Retrospective Studies
  • Schizophrenia (drug therapy)
  • White People (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: